Antibody–drug conjugates in solid tumors: Efficacy, challenges, and opportunities

Journal of Experimental Medicine · Published 2026-07-24 · DOI 10.1084/jem.20252603

Authors (2)

Nakul M. Shah, Funda Meric-Bernstam

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Shah, N., Meric-Bernstam, F. (2026). Antibody–drug conjugates in solid tumors: Efficacy, challenges, and opportunities. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20252603

Related articles

• Emerging Antibody-Drug Conjugate Therapies and Targets for Metastatic Renal Cell Carcinoma · Kidney Cancer · 2023 · Cites or is cited by this article
• Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters · Cancer Drug Resistance · 2026 · Cites or is cited by this article
• A review of conjugation technologies for antibody drug conjugates · Antibody Therapeutics · 2025 · Cites or is cited by this article
• Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors · Antibody Therapeutics · 2025 · Cites or is cited by this article
• Leveraging cDC1 biology and function for enhanced immunotherapy · Journal of Experimental Medicine · 2026 · Same journal
• Aquaporin-1 sustains lymphangiogenic responses in hyperosmotic inflammatory microenvironments · Journal of Experimental Medicine · 2026 · Same journal
• CNOT3 supports ILC2 differentiation and function by destabilizing Tbx21 and Rorc transcripts · Journal of Experimental Medicine · 2026 · Same journal
• Flawed translation triggers oncogenic B–T cell communication · Journal of Experimental Medicine · 2026 · Same journal
• Identification of secondary microglial formation centers in the human fetal brain · Journal of Experimental Medicine · 2026 · Same journal
• eIF3e-mediated translational checkpoint maintains immune tolerance and prevents lymphoid malignancy · Journal of Experimental Medicine · 2026 · Same journal